Assessing self-reported use of new psychoactive substances: The impact of gate questions-Reference-Cited by-同舟云学术

Assessing self-reported use of new psychoactive substances: The impact of gate questions

Published:2017-05-09 Issue:5 Volume:43 Page:609-617
ISSN:0095-2990
Container-title:The American Journal of Drug and Alcohol Abuse
language:en
Short-container-title:The American Journal of Drug and Alcohol Abuse

Author:

Palamar Joseph J.¹²,Acosta Patricia¹,Calderón Fermín Fernández³^ORCID,Sherman Scott¹²,Cleland Charles M.²⁴

Affiliation:

1. Department of Population Health, New York University Langone Medical Center, New York, NY, USA

2. Center for Drug Use and HIV Research, New York University Rory Meyers College of Nursing, New York, NY, USA

3. Department of Clinical, Experimental and Social Psychology, University of Huelva, Huelva, Spain

4. New York University Rory Meyers College of Nursing, New York, NY, USA

Funder

National Institute on Drug Abuse

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/00952990.2017.1322094

Reference43 articles.

1. US Drug Enforcement Administration, Office of Diversion Control. National Forensic Laboratory Information System Special Report: Synthetic Cannabinoids and Synthetic Cathinones Reported in NFLIS, 2013–2015. Springfield, VA: US Drug Enforcement Administration; 2016.

2. US Drug Enforcement Administration, Office of Diversion Control. National Forensic Laboratory Information System Special Report: 2C-Phenethylamines, Piperazines, and Tryptamines Reported in NFLIS, 2011–2015. Springfield, VA: US Drug Enforcement Administration; 2017.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective;Brain Sciences;2024-03-29

2. Psychometric properties of the Alzheimer’s Disease Cooperative Study – Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial;BMC Geriatrics;2023-03-06

3. Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis;Basic & Clinical Pharmacology & Toxicology;2022-09-05

4. Electronic health record data may lead to underestimates of cannabis use—Especially among older populations;Journal of the American Geriatrics Society;2022-03-02

5. A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure;Biology;2021-08-17